Nancy L. Dawson

Nancy L. Dawson

Auto-generated profile, based on publicly available information

Nancy L. Dawson

Mayo Clinic, Jacksonville, FL

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2021 in Journal of General Internal Medicine
Verified
Journal Article
Closed access
PDF file
NDNancy L. Dawson
Nancy L. Dawson
BHBryan P. Hull
Bryan P. Hull
PVPriyanka Vijapura
Priyanka Vijapura
ADAdrian G. Dumitrascu
Adrian G. Dumitrascu
CBColleen T. Ball
Colleen T. Ball
MBM. Caroline Burton
M. Caroline Burton

1 July 2011 in Medicine
Verified
Journal Article
Closed access
NDNancy L. Dawson
Nancy L. Dawson
LBLisa M. Brumble
Lisa M. Brumble
BPBobbi Pritt
Bobbi Pritt
JYJoseph D. Yao
Joseph D. Yao
JEJ. Dan Echols
J. Dan Echols
SASalvador Alvarez
Salvador Alvarez
We aimed to determine the clinical features, predisposing factors, and outcome of left-sided Pseudomonas aeruginosa endocarditis in persons with no history of injection drug use. We performed a retrospective review of patient medical records from Mayo Clinic (Rochester, MN; Scottsdale, AZ; and Jacksonville, FL) for all cases of left-sided P. aeruginosa endocarditis. We identified 4 cases. We present these cases, as well as a review of the English-language medical literature. Data gathered included the year the case was reported; the valve involved; treatment, including valve replacement surgery; and outcome, if known. Left-sided P. aeruginosa endocarditis in persons without injection drug use is a rare but serious infection, with a history of instrumentation as a common predisposing condition. Valvular surgery is indicated, when possible, for the best chance of survival, along with extended therapy with combination antibiotics for complete recovery.

1 March 2018 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
NDNancy L. Dawson
Nancy L. Dawson
CLChristian Lachner
Christian Lachner
TVTyler F. Vadeboncoeur
Tyler F. Vadeboncoeur
MMMichael J. Maniaci
Michael J. Maniaci
VBVeronica Bosworth
Veronica Bosworth
MBM. Caroline Burton
M. Caroline Burton

31 July 2022 in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Verified
Journal Article
Open access
BMBala Munipalli
Bala Munipalli
SSShelby Strothers
Shelby Strothers
FRFernando Rivera
Fernando Rivera
PMPedro Malavet
Pedro Malavet
GMGhada Mitri
Ghada Mitri
NDNancy L. Dawson
Nancy L. Dawson
To assess the association between vitamin B12 (B12) deficiency and the prevalence of fatigue and prespecified neurologic symptoms in patients with fibromyalgia. A retrospective chart analysis of patients diagnosed with fibromyalgia in the years 2015-2020 was performed. The values of B12 were collected. The chart reviews assessed reported fatigue and neurologic symptoms, including brain fog, memory loss, cognitive impairment, paresthesias, numbness, and tingling, to assess their correlation with B12 levels. Concurrent vitamin D and thyroid-stimulating hormone levels were reviewed to assess their association with fibromyalgia. A total of 2142 patients with fibromyalgia with documented levels of B12 and vitamin D were included. Of them, 42.4% had B12 deficiency (<400 ng/L). Fatigue and memory loss were more common in the B12 deficiency group. After adjusting for vitamin D levels, B12 deficiency remained statistically significantly associated with the presence of fatigue (odds ratio, 1.39; 95% confidence interval, 1.11-1.75; P=.004). This is the first study to report the association of B12 in patients with fibromyalgia complaining of fatigue. This symptom was prevalent in our group of patients with fibromyalgia with B12 deficiency, regardless of whether the cutoff point was 400 or 350 ng/L.

13 November 2011 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
NDNancy L. Dawson
Nancy L. Dawson
IPIvan E. Porter
Ivan E. Porter
DKDusko Klipa
Dusko Klipa
WBWilliam R. Bamlet
William R. Bamlet
MHMary Ann Hedges
Mary Ann Hedges
APAlden V. Patel
Alden V. Patel

1 June 2022 in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Verified
Journal Article
Open access
RGRavindra Ganesh
Ravindra Ganesh
GVGreg S. Vanichkachorn
Greg S. Vanichkachorn
BMBala Munipalli
Bala Munipalli
SHSara N. Hanson
Sara N. Hanson
ADAbd Moain Abu Dabrh
Abd Moain Abu Dabrh
RHRyan T. Hurt
Ryan T. Hurt
To outline a consensus-designed process for triaging and managing patients with post-coronavirus disease (COVID-19) syndrome at Mayo Clinic. We convened a central multidisciplinary team including members from the departments of general internal medicine, occupational medicine, physical medicine and rehabilitation, psychology, allergy and immunology, infectious disease, pulmonology, neurology, cardiology, and pediatrics and otorhinolaryngology with membership from all Mayo Clinic sites in Arizona, Florida, Iowa, Minnesota, and Wisconsin. Consensus recommendations were made for the best practice guidelines on triaging and managing patients. Several innovations were agreed upon, including a postacute sequelae of COVID-19-specific appointment request form for data collection, a bioregistry, a biorepository, and a postacute sequelae of COVID-19-specific treatment program. Given that each clinical site had individual clinical practices, these recommendations were implemented using different models, which may provide broad applicability to other clinical settings.